CHAPEL HILL, N.C., Dec. 11, 2024 /PRNewswire/ -- Research spending at Carolina has topped $1.55 billion, fueling the state's economy,…
New AARP CEO Dr. Myechia Minter-Jordan to Discuss Innovations Shaping the Future of Aging and Well-Being WASHINGTON, Dec. 11, 2024…
Domi strengthens the #AiresAthletes campaign, reinforcing the importance of protection from EMF radiation to enhance recovery and overall well-being* Domi…
Inretio presents initial clinical trial results at prestigious BRAIN Conference 2024 in London.Toronto, Ontario--(Newsfile Corp. - December 11, 2024) -…
Presentation to Feature Lead Drug Candidate GT-02287 and Magellan Drug Discovery PlatformBETHESDA, Md., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Gain…
– Findings published in Brain Sciences showed missed doses and potential for injury when waking to take a second dose…
Median overall survival (OS) to date of 13.4 months for Phase 2 patients treated with the Phase 3 formulation (15.6…
The ongoing obesity Phase 2 trial is a randomized, double-blind, placebo-controlled, dose finding, clinical trial to evaluate the safety and…
Grant for "Personalized Medicine Enabled by Intelligent Sensing Systems” ProjectMUNICH, Dec. 11, 2024 (GLOBE NEWSWIRE) -- HMNC Brain Health, a…
SHANGHAI, Dec. 11, 2024 /PRNewswire/ -- On November 11, Syrebo showcased several innovative rehabilitation robot products at MEDICA 2024 in…